Our analysis of gene expression from neuroblastoma tumor datasets uncovered a significant association for RYK and ROR2—but not for ROR1—to a worse survival probability in 6 out of 10 cohorts (Fig. 2 top subset and Fig. 5a). The gene discussed is ROR1; the disease is neoplasm.